|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| A61P 35/00 | |||
| C07K 16/28 | |||
| C07K 16/30 | |||
| A61K 39/00 | |||
| A61K 39/395 | |||
| G01N 33/574 |
| (11) | Number of the document | 3193933 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15772128.3 |
| Date of filing the European patent application | 2015-09-16 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/050365 |
| Date | 2015-09-16 |
| (87) | Number | WO 2016/044383 |
| Date | 2016-03-24 |
| (30) | Number | Date | Country code |
| 201462051650 P | 2014-09-17 | US |
| (72) |
DIMITROV, Dimiter S., US
ZHU, Zhongyu, US
ST. CROIX, Bradley, US
SEAMAN, Steven, US
SAHA, Saurabh, US
ZHANG, Xiaoyan Michelle, US
DECRESCENZO, Gary A., US
WELSCH, Dean, US
|
| (73) |
The U.S.A. as represented by the Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660,
US
Biomed Valley Discoveries, Inc., 4520 Main Street 16th Floor, Kansas City, Missouri 64111, US |
| (54) | ANTI-CD276 ANTIBODIES (B7H3) |
| ANTI-CD276 ANTIBODIES (B7H3) |